GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).
Katzdobler S, Nübling G, Klietz M, Fietzek UM, Palleis C, Bernhardt AM, Wegner F, Huber M, Rogozinski S, Schneider LS, Spruth EJ, Beyle A, Vogt IR, Brandt M, Hansen N, Glanz W, Brockmann K, Spottke A, Hoffmann DC, Peters O, Priller J, Wiltfang J, Düzel E, Schneider A, Falkenburger B, Klockgether T, Gasser T, Nuscher B, Haass C, Höglinger G, Levin J.
Katzdobler S, et al. Among authors: hansen n.
J Neurol. 2024 Oct;271(10):6991-6999. doi: 10.1007/s00415-024-12647-z. Epub 2024 Sep 10.
J Neurol. 2024.
PMID: 39254698
Free PMC article.